Login / Signup

COVID-19 and Telepsychiatry: Development of Evidence-Based Guidance for Clinicians.

Katharine Alison SmithEdoardo Giuseppe OstinelliOrla MacdonaldAndrea Cipriani
Published in: JMIR mental health (2020)
We produced a comprehensive synthesis of guidance answering a wide range of clinical questions in telepsychiatry. This meets the urgent need for practical information for both clinicians and health care organizations who are rapidly adapting to the pandemic and implementing remote consultation. It reflects variations across countries and can be used as a basis for organizational change in the short- and long-term. Providing easily accessible guidance is a first step but will need cultural change to implement as clinicians start to view telepsychiatry not just as a replacement but as a parallel and complementary form of delivering therapy with its own advantages and benefits as well as restrictions. A combination or hybrid approach can be the most successful approach in the new world of mental health post-COVID-19, and guidance will need to expand to encompass the use of telepsychiatry in conjunction with other in-person and digital technologies, and its use across all psychiatric disorders, not just those who are the first to access and engage with remote treatment.
Keyphrases
  • coronavirus disease
  • sars cov
  • palliative care
  • mental health
  • healthcare
  • stem cells
  • bone marrow
  • health information
  • combination therapy
  • cell therapy
  • health insurance